Cutaneous Anaplastic Large Cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2010-04-26
Clinical Trial Update: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma [Phase 2]
This Phase 2 trial evaluating MDX-060 in relapsed or refractory anaplastic large cell lymphoma (systemic and primary cutaneous) has been wit…